Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 31;11(1):629.
doi: 10.1186/s13104-018-3738-2.

A systematic review: the current status of carbapenem resistance in East Africa

Kenneth Ssekatawa  1   2 , Dennis K Byarugaba  3 , Edward Wampande  3 , Francis Ejobi  3
Affiliations

A systematic review: the current status of carbapenem resistance in East Africa

Kenneth Ssekatawa et al. BMC Res Notes. .

Abstract

Objective: In this systematic review, we present the molecular epidemiology and knowledge gaps of the carbapenem resistance in East Africa as well as the future probable research interventions that can be used to address the emergence of carbapenem resistance in the region.

Results: The 17 articles which presented concrete information about the prevalence of carbapenem resistance in East Africa were reviewed. Tanzania exhibited the highest level of carbapenem resistance at 35% while DRC had the lowest level at 0.96%. Uganda was the only country with studies documenting CR obtained amongst hospital environment isolates with incidence ranging from 21% in Pseudomonas aeruginosa to 55% in Acinetobacter baumannii. Carbapenem resistance was more exhibited in A. baumannii (23%), followed by P. aeruginosa (17%), Klebsiella pneumoniae (15%), Proteus mirabilis (14%) and Escherichia coli (12%) mainly isolated from respiratory tract, blood, urine and wound/pus. The regional genetic determinants of carbapenem resistance detected were blaIMP, blaVIM-1 blaSPM-l, blaNDM-1, blaOXA-23 blaOXA-24, blaOXA-58 and blaKPC.

Keywords: Carbapenem resistance; East Africa; Molecular epidemiology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Selection process of research articles for inclusion in this systematic review
See this image and copyright information in PMC

References

    1. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carbapenem resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37:415–424. doi: 10.1016/j.ijantimicag.2011.01.012. - DOI - PubMed
    1. CDC . Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) Atlanta: United States Department of Health and Human Services; 2015.
    1. European Centre for Disease Prevention and Control-ECDC . Rapid risk assessment-carbapenem-resistant Enterobacteriaceae. Stockholm: ECDC; 2016.
    1. European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC) EU summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2013. EFSA J. 2015;13:4036. - PMC - PubMed
    1. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi: 10.1016/j.molmed.2012.03.003. - DOI - PubMed

Publication types